Workflow
Arcus Biosciences (RCUS) Soars 8.5%: Is Further Upside Left in the Stock?

Arcus Biosciences, Inc. (RCUS) shares rallied 8.5% in the last trading session to close at $14.48. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 9.5% gain over the past four weeks.The price rise can be attributed to growing investor confidence in the company’s progress with its pipeline candidates, which are being developed as monotherapies and in combination studies targeting various types of cancer indica ...